|
CRI, Kasauli becomes cGMP compliant facility for mfg DPT & TT vaccines
|
|
Our Bureau, Mumbai
April 30 , 2016
|
|
|
The Central Research Institute (CRI), Kasauli in Himachal Pradesh has
become the first of its kind current good manufacturing practice (cGMP)
compliant facility within the central government for manufacture of DPT
and TT vaccines.
Union minister for health and family welfare J P
Nadda inaugurated the facility which makes CRI the first central
government institute to have cGMP compliant infrastructure for vaccine
production.
TT vaccine has been commercialised from this facility
for Universal Immunisation Programme use and production of DPT bulk has
been initiated. It is essential for vaccine manufacturers to have
global quality standards, and CRI is exploring the feasibility of
establishing WHO prequalified cGMP compliant manufacturing facility for
yellow fever vaccine. This will enable the institute to supply yellow
fever vaccine to African and Latin American countries.
CRI has
been working as one of the few pioneer institutions in the field of
vaccine manufacturing. The institute has plans to manufacture all
vaccines viz., Japanese encephalitis vaccine, rabies vaccine and typhoid
vaccine, which were earlier manufactured in the institute, after
establishing cGMP compliant facilities and application of recent
technological advancements. CRI has also plans to create state of the
art, fully dedicated cGMP compliant laboratory for research on vaccine
development and various other public health related issues. The
institute plans to undertake research on newer vaccine candidates for
existing and emerging diseases and to manufacture more efficacious and
safer vaccines as also to contribute to the prevention of spread of
novel antigenic variants.
Besides, as part of its expansion
plans, CRI is in process of acquiring 128 bighas of land from Himachal
Pradesh government for creation of cGMP compliant facility for
manufacturing of therapeutic anti-sera. This initiative will increase
the production capacity of the institute to cater to the ever increasing
demand of these lifesaving anti-sera and also generate significant
amount of employment opportunities for country’s youth. Manufacture of
immunobiologicals and animal care is an important and highly technical
field which requires trained manpower at every level. For skill
development in this area, CRI is initiating a certificate course in
‘Production of Immunobiologicals and Animal Care’, affiliated to the
State Council of Vocational Training, Himachal Pradesh. This course will
play a significant role in developing trained manpower to work in
various health, research and pharmaceutical setups and provide plethora
of opportunities for youth of the country.
CRI, Kasauli is one of
the most important suppliers of vaccines for the government’s UIP
especially for DPT and TT vaccines. The institute is involved in
manufacture and supply of various lifesaving therapeutic antisera for
snake bites, rabies and diphtheria, and supplies yellow fever vaccine to
different parts of the country. Diagnostic reagents such as diagnostic
antigens for typhoid, typhus fever and brucellosis and diagnostic
antisera for cholera and salmonella are also manufactured and supplied
to various institutions throughout the country.
The health minister also launched the website of CRI on the occasion.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|